Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Comments To: Response to Bevacizumab after Treatment with Aflibercept in Eyes with Neovascular AMD

European Journal of Ophthalmology

Impact Factor: 1.3 / 5-Year Impact Factor: 1.6

Journal Homepage Submission guidelines

Restricted access

Letter

First published online September, 2016

Comments To: Response to Bevacizumab after Treatment with Aflibercept in Eyes with Neovascular AMD

and

Volume 26, Issue 5

https://doi.org/10.5301/ejo.5000845

Abstract

Get full access to this article

View all access options for this article.

References

1.

Waizel

M

Rickmann

A

Blanke

BR

Wolf

K

Kazerounian

S

Szurman

P

Response to bevacizumab after treatment with aflibercept in eyes with neovascular AMD. Eur J Ophthalmol 2016; 26(5): 469–472

2.

Grover

S

Murthy

RK

Brar

VS

Chalam

KV

Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis). Am J Ophthalmol 2009; 148(2): 266–271

Browse journal

Current issue OnlineFirst All issues

Similar articles

Available access

Europe and the Christian Democracy Movement: A Once and Future Hope?

Available access

Solvent viscosity effects on protein dynamics studied by ultrasonic absorption

Restricted access

Exploratory Grant Program in Diabetes,Endocrinology,and Metabolism: Pa-04-137

Restricted access

Physician Satisfaction with Current Psoriasis Treatment: A Real-World Study in the USA